Better Collaboration Between Pharma and Patient Organizations Would Improve Patient Care, Accenture Study Finds
Last accenture plc class a ordinary shares (ireland) earnings: 3/19 06:44 am
Check Earnings Report
US:NYSE Investor Relations: investor.accenture.com
Despite preferring services from patient organizations over those from pharmaceutical companies, patients want both to work together to provide a more seamless patient experience FRANKFURT, Germany & NEW YORK--(BUSINESS WIRE)--To deliver better patient experiences, pharmaceutical companies should collaborate with nonprofit organizations that provide support services and advocate for patients, according to a new study from Accenture (NYSE:ACN).This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190807005606/en/How willing would you be to share detailed information about the daily impact of your condition with each of the following organizations, if it helped you receive better care?Based on a survey of 4,000 patients in the U.S. and Europe, the Patient Services Study investigates the role that patient organizations play in providing support, information and other services to patients and whether better collaboration with pharm
[Read more]
| Impact snapshot | Event time: | ACN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
ACN alerts
ACN alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACN alerts
High impacting Accenture plc Class A Ordinary Shares (Ireland) news events
Weekly update
A roundup of the hottest topics
ACN
News
- Accenture plc (<a href="https://www.marketbeat.com/stocks/NYSE/ACN/price-target/">NYSE: ACN</a>) was upgraded by analysts at Moffett Nathanson from a "neutral" rating to a "buy" rating. They now have a $405.00 price target on the stock.MarketBeat
- Accenture to Host Conference Call Tomorrow, Sept. 23, to Discuss Fourth-Quarter and Fiscal Year 2021 ResultsBusiness Wire
- Accenture and the World Economic Forum Decode the “Sustainability DNA” for Companies Seeking to Deliver Value and Impact for All StakeholdersBusiness Wire
- Two-Thirds of Consumers are “Sustainability-Minded Drivers,” Accenture Report FindsBusiness Wire
- Accenture Helps Vivienne Westwood Develop and Launch Products Faster With New Retail PLM Platform From PTCBusiness Wire
- More
ACN
SEC Filings
- 9/10/21 - Form 4
- 9/7/21 - Form 4
- 9/7/21 - Form 4
- ACN's page on the SEC website
- More